Pfizer COVID-19 Vaccine Gets Full FDA Approval

Last Updated: Aug 23, 2021

On Aug. 23, 2021, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. Learn more from the FDA here.

The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Login to be able to comment

Leave a comment

ng5136-PA-PAMedSociety-DigitalAd-Brand-970x90